EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

NLRP3 is a BMI-independent mediator of stable COPD

Yonca Gungor, Selin Ercan, Saliha Selin Özuygur Ermiş, Yiğit Kozalı, Gizem Kursunluoglu, Ceyda Sahan, Aylin Ozgen Alpaydin, Hulya Ayar Kayali

BMC Pulmonary Medicine · 2025

DOI: 10.1186/s12890-024-03435-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Pulmonary Medicine, 2025. Verfasst von Yonca Gungor und 7 weiteren Autor:innen. Beteiligte Einrichtung: İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir, Türkiye. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Pulmonary Disease, Chronic Obstructive, Body Mass Index. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The inflammatory response in animal models of chronic obstructive pulmonary disease (COPD) is activated by the NLR-family-pyrin-domain-containing-3 (NLRP3) inflammasome pathway, which is also known to play a role in obesity-related inflammation. The NLRP3/caspase-1/interleukin (IL)-1β pathway might be involved in the progression of COPD with increasing body mass index. To our knowledge, no previous studies have explored the role of NLRP3 inflammasome markers in linking COPD and obesity. Here, we aim to investigate this potential connection by examining levels of NLRP3, caspase-1, IL-1β, and IL-17A and to provide additional data on the expression of these molecules in relation to smoking status and COPD severity. METHODS: A case‒control study was conducted between July 2020 and March 2023. Peripheral blood mononuclear cells were isolated, and total RNA was extracted for real-time quantitative polymerase chain reaction (qPCR) analysis to measure the expression levels of inflammasome molecules. RESULTS: 29 subjects who were diagnosed with stable COPD and 32 controls were included in the data analysis. NLRP3 and IL-17A but not caspase-1 or IL-1β expression was significantly greater in the COPD group than in the control group. We detected a significant increase in NLRP3 levels in the smoker COPD group (p = 0.009) and nonsmoker COPD group (p = 0.045) compared with those in the nonsmoker control group. There was no significant correlation between BMI and the inflammasome markers. CONCLUSION: As proinflammatory biomarkers, NLRP3 and IL-17A are prominent in stable COPD patients. Smoking may trigger NLRP3-mediated inflammation in stable COPD patients. The expression levels of NLRP3 inflammasome molecules did not differ in terms of disease severity or BMI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinPulmonary Disease, Chronic ObstructiveBody Mass IndexHumansMaleFemaleMiddle AgedAgedCase-Control StudiesInterleukin-1betaInterleukin-17Caspase 1InflammasomesSmokingObesityBiomarkersSeverity of Illness IndexLeukocytes, Mononuclear

Stichwörter der Autor:innen

COPDIL-17AInflammasomeNLRP3ObesitySmoking

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanInterleukin-1betaInterleukin-17Caspase 1InflammasomesIL17A protein, humanBiomarkersIL1B protein, human

Autor:innen und Institutionen

  • İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir, Türkiye.
  • İzmir Biomedicine and Genome Center, İzmir, Türkiye.
  • Krefting Research Centre, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Biotechnology, The Graduate School of Natural and Applied Sciences, Dokuz Eylul University, İzmir, Türkiye.
  • ERFARMA Drug Application and Research Center, Erciyes University, Kayseri, Türkiye.
  • Department of Public Health, Dokuz Eylul University, İzmir, Türkiye.

Zitieren

APA

Gungor, Y., Ercan, S., Ermiş, S. S. Ö., Kozalı, Y., Kursunluoglu, G., Sahan, C., Alpaydin, A. O., & Kayali, H. A. (2025). NLRP3 is a BMI-independent mediator of stable COPD. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-024-03435-6

Vancouver

Gungor Y, Ercan S, Ermiş SSÖ, Kozalı Y, Kursunluoglu G, Sahan C, et al. NLRP3 is a BMI-independent mediator of stable COPD. BMC Pulmonary Medicine. 2025. doi:10.1186/s12890-024-03435-6

BibTeX
@article{Gungor2025,
  author = {Gungor, Yonca and Ercan, Selin and Ermiş, Saliha Selin Özuygur and Kozalı, Yiğit and Kursunluoglu, Gizem and Sahan, Ceyda and Alpaydin, Aylin Ozgen and Kayali, Hulya Ayar},
  title = {NLRP3 is a BMI-independent mediator of stable COPD},
  journal = {BMC Pulmonary Medicine},
  year = {2025},
  doi = {10.1186/s12890-024-03435-6}
}
Kostenlos starten →